The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis
Osteoarthritis (OA) is one of the most common diseases of the musculoskeletal system, affecting mainly people of old age. The management of OA requires combined therapy using pharmaceutical and nonpharmacological modalities, including hyaluronic acid (HA). Hylans are highmolecular-weight (HMW) HA de...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2017-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/740 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849691526947405824 |
|---|---|
| author | S. G. Anikin |
| author_facet | S. G. Anikin |
| author_sort | S. G. Anikin |
| collection | DOAJ |
| description | Osteoarthritis (OA) is one of the most common diseases of the musculoskeletal system, affecting mainly people of old age. The management of OA requires combined therapy using pharmaceutical and nonpharmacological modalities, including hyaluronic acid (HA). Hylans are highmolecular-weight (HMW) HA derivatives. The use of hylans results in reducing pain and stiffness and in improving functional activity. Their efficacy is comparable with that of lowmolecular-weight HA. Intraarticular injection of HMW HA derivatives is safe and effective for treating OA. |
| format | Article |
| id | doaj-art-a98502f6d65f4f06aceb9e330b70f6c2 |
| institution | DOAJ |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2017-03-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-a98502f6d65f4f06aceb9e330b70f6c22025-08-20T03:20:59ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2017-03-01111626510.14412/1996-7012-2017-1-62-652022The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritisS. G. Anikin0V.A. Nasonova Research Institute of RheumatologyOsteoarthritis (OA) is one of the most common diseases of the musculoskeletal system, affecting mainly people of old age. The management of OA requires combined therapy using pharmaceutical and nonpharmacological modalities, including hyaluronic acid (HA). Hylans are highmolecular-weight (HMW) HA derivatives. The use of hylans results in reducing pain and stiffness and in improving functional activity. Their efficacy is comparable with that of lowmolecular-weight HA. Intraarticular injection of HMW HA derivatives is safe and effective for treating OA.https://mrj.ima-press.net/mrj/article/view/740osteoarthritistreatmenthyaluronic acidhighmolecular-weight hyaluronic acid |
| spellingShingle | S. G. Anikin The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis Современная ревматология osteoarthritis treatment hyaluronic acid highmolecular-weight hyaluronic acid |
| title | The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis |
| title_full | The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis |
| title_fullStr | The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis |
| title_full_unstemmed | The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis |
| title_short | The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis |
| title_sort | use of highmolecular weight hyaluronic acid in the treatment of osteoarthritis |
| topic | osteoarthritis treatment hyaluronic acid highmolecular-weight hyaluronic acid |
| url | https://mrj.ima-press.net/mrj/article/view/740 |
| work_keys_str_mv | AT sganikin theuseofhighmolecularweighthyaluronicacidinthetreatmentofosteoarthritis AT sganikin useofhighmolecularweighthyaluronicacidinthetreatmentofosteoarthritis |